These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11273228)

  • 21. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving survival among HIV-infected injection drug users: how should we define success?
    Kirk GD; Vlahov D
    Clin Infect Dis; 2007 Aug; 45(3):377-80. PubMed ID: 17599318
    [No Abstract]   [Full Text] [Related]  

  • 23. Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA study.
    Dragsted UB; Mocroft A; Vella S; Viard JP; Hansen AB; Panos G; Mercey D; Machala L; Horban A; Lundgren JD;
    J Infect Dis; 2004 Jul; 190(1):148-55. PubMed ID: 15195254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges of antiretroviral treatment in transient and drug-using populations: the SUN study.
    Sension MG; Farthing C; Shaffer AG; Graham E; Siemon-Hryczyk P; Pilson RS
    AIDS Patient Care STDS; 2001 Mar; 15(3):129-36. PubMed ID: 11313025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
    Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS
    HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response.
    Fardet L; Mary-Krause M; Heard I; Partisani M; Costagliola D;
    HIV Med; 2006 Nov; 7(8):520-9. PubMed ID: 17105511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months.
    Engsig FN; Omland LH; Larsen MV; Rasmussen LD; Qvist T; Gerstoft J; Obel N
    HIV Med; 2010 Aug; 11(7):457-61. PubMed ID: 20158527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.
    Celentano DD; Galai N; Sethi AK; Shah NG; Strathdee SA; Vlahov D; Gallant JE
    AIDS; 2001 Sep; 15(13):1707-15. PubMed ID: 11546947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus quasispecies in HIV-infected women: role of injecting drug use and highly active antiretroviral therapy (HAART).
    Laskus T; Wilkinson J; Karim R; Mack W; Radkowski M; deGiacomo M; Nasseri J; Chen Z; Xu J; Kovacs A
    Hepatology; 2007 Aug; 46(2):359-70. PubMed ID: 17659581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy.
    Ing EC; Bae JW; Maru DS; Altice FL
    AIDS Behav; 2013 Jan; 17(1):113-21. PubMed ID: 22105340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
    Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
    CMAJ; 2003 Sep; 169(7):656-61. PubMed ID: 14517122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
    Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
    Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients: the role of intravenous drug use.
    Dronda F; Zamora J; Moreno S; Moreno A; Casado JL; Muriel A; Pérez-Elías MJ; Antela A; Moreno L; Quereda C
    AIDS; 2004 Nov; 18(16):2210-2. PubMed ID: 15577659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombocytopenia in HIV-infected drug users in the HAART era.
    Burbano X; Miguez MJ; Lecusay R; Rodriguez A; Ruiz P; Morales G; Castillo G; Baum M; Shor-Posner G
    Platelets; 2001 Dec; 12(8):456-61. PubMed ID: 11798394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compliance with antiretroviral regimens.
    Laurence J
    AIDS Read; 2001 Apr; 11(4):177, 181. PubMed ID: 11392675
    [No Abstract]   [Full Text] [Related]  

  • 36. Access to antiretroviral therapy in HIV-infected injection drug users.
    Antela A
    AIDS; 2001 Sep; 15(13):1727-8. PubMed ID: 11546949
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonadherence to antiretroviral therapy among a community with endemic rates of injection drug use.
    Shannon K; Kerr T; Lai C; Ishida T; Wood E; Montaner JS; Hogg RS; Tyndall MW
    J Int Assoc Physicians AIDS Care (Chic); 2005 Jul; 4(3):66-72. PubMed ID: 16867974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cohort analysis of two multidisciplined adherence intervention programmes for patients on antiretroviral therapy.
    Doxanakis A; Read T; Levy R; Mijch A; Fairley CK
    Int J STD AIDS; 2006 Apr; 17(4):257-9. PubMed ID: 16595049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.